MDT Stock Recent News

Buying dividend stocks is always a smart plan. They have historically outperformed non-dividend payers by more than two-to-one (9.2% annualized return compared to 4.3% over the last 50 years, according to data from Hartford Funds and Ned Davis Research).

Medtronic (MDT) reachead $84.30 at the closing of the latest trading day, reflecting a +0.66% change compared to its last close.

The latest trading day saw Medtronic (MDT) settling at $83.75, representing a +0.46% change from its previous close.

In recent months, Medtronic has soundly outperformed the S&P 500 index. The company's recent regulatory approvals should bode well for non-GAAP EPS growth in the coming years. Medtronic's interest coverage and net debt to EBITDA ratios are robust.

Investors increasingly seek stable and resilient investments in today's volatile and economically uncertain market. Consequently, it is crucial to identify companies with strong fundamentals, defensive strategies, and dependable shareholder returns.

Medtronic offers a compelling long-term investment opportunity with solid revenue and earnings growth, driven by innovation in the cardiovascular, neuromodulation, and diabetes care segments. Medtronic's 3.4% dividend yield is well-supported by earnings, and management continues to invest in R&D to drive shareholder returns. With a forward P/E of 15.1 versus a historical norm of 18.2, MDT is attractively valued amidst improving margins and demographic tailwinds from an aging population.

Medtronic (MDT) concluded the recent trading session at $82.60, signifying a -0.12% move from its prior day's close.

Bill George, executive fellow at Harvard Business School and former CEO and chairman of Medtronic, joins Market Domination Overtime to discuss the most recent tariff developments. George emphasizes how President Trump's tariff policies and policy adjustments erode other nations' trust in the United States.

Dividend stocks are great long-term investments. They've outperformed non-dividend-paying stocks by more than 2-to-1 over the long term.

In the latest trading session, Medtronic (MDT) closed at $88.86, marking a +0.42% move from the previous day.